What is the catalog number for PEGLN1 (human) -Fluc?

The catalog number for PEGLN1 (human) -Fluc is BZ62568.

What sizes are available for PEGLN1 (human) -Fluc?

PEGLN1 (human) -Fluc is available in the following size(s): 1 Vial.

Is PEGLN1 (human) -Fluc in stock?

PEGLN1 (human) -Fluc is currently made to order / not held in immediate stock. Contact us for lead time.

Can this product be used for co-immunoprecipitation (Co-IP)?

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.

Is this kit compatible with automated liquid handling platforms?

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

What applications has this product been validated for?

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

PEGLN1 (human) -Fluc – Buy Online at

ATAGTACTAACATACGCTCTCCATCAAAACAAAACGAAACAAAACAAACTAGCAAAATAGGCTGTCCCCAGTGCAAGTGCAGGTGCCAGAACATTTCTCTGGCCTAACTGGCCGGTACCTGATGGTATTAGGTGGGGCGGGGTGGAGGAAGAAACAACTAAGTGCAATGTATGGACTTGTTTAGATCTTGAATTGAATAAAGCAACTGTAAACAGAATCTTTGATATAATCGAAAAAAATTTAATACTTGGAGGATGATGGATAGTATTGAGATTTTTCTTAATTTTGTGTGATAATGGCATGGTGGATATGATTTTTGAAAGTTCTTATCAGATGTGCATATTGAAGTTGGGATATGCTTTATAATACTTTAGCAAAAAAAGTGGGGGACATAGTAGGGAGGAGGGTAGGGAAGAATTGTCTATCAACAAATGTTGATAATTGTTGAAGCTGATAACTGTTGAACTCATTAGGGCTGAGGTTGATTATACTATTATCTCTCTTTTTGCATATGTTTAACTTTTCCCACAAGAAAATGTTACAGGAAAAATTATTTAGCTTTCTCCAACCTGGGTTGGTATAAGTCACTGATTGTGACTATCCCAAAAGTTGGTTCAACATTAAGGTAATGTTTGTTAGGAAAAAAAATTAGATCGACACGTTATTTAGTATCCCAGGTTTTTGAGCATTTATTTAAAAAATTCGCTATAATGAGAGATGATTATAAATTTTTGTTATATTTCTGAGATGATCAATTTTAACAGGATTGGTGGTAATTTTTCAATCATAAACTGATAAAGTTTGATGACTGATAAATCGCCCCAATATATAGCAAATCTATTCAATTATTTTGTTTTCATAAGGGAACAACCTTGGTGGAAAGTACAGCTGTCTCCATGTACAAGGAGAAGCACATAGCTCACGTGTGCATCTGGCAGAACCCCCAGTACAGAGACAAGCAGGTGCTGTTTTCCAATGACACCTACTTGTGTGTGTCCTAATACTATAGTTAGAAAATGGCTCAGATTTTTGAGTTGCTTTTCCCAGAACTCAAAGATTGTCTTCCTGTTTATCTTGGTGGAATGCCTATGCTATACTTGTGATTTTTCTGTTCTCTGTAACCTATTAAAACAAGATTGTCACAGATGGGGAAACAAGAGGTCATTAGTTAACAATCAGATGTTCGATTTCTTGAGCAGAAAAGATACTCTGTTGTGTTTTTAAAAACATTTTTAAAGGAGAAATAGGGCTACTCCTTGGAAGGCAGATTGTTGTTCAGTGGGCTTTCCTCAAGAGTCAACACAGTCGTTTCTAAATTCATTTCCTCCTTCAATTCTGTTCTTGTAGTTAACATAAGCTTTGCCTCTTTTAGTTCTTGTCAGTTCACAGTGGCTACTTCTTTATAGCTTAACTAAATACTGCCAGAAGAGCAAAGGGAAGCCAAATAGGTGGTCAATTAGCTTTGTCTAAGTTGGTATGATATGGAGAGGAAAGCACTGTTACTTTAATTCATTCTTCAGTTTCTAGAACAGTTGCTTTTGATTAGGTTAGGGGCAGAAAAACATTTGTAATAATTAATGGCTTTGAGAGACACAAGGCTTTGTTTGCCCCAGAGTATTAGTTAACCCACCTAGTGCTCCTAATCATACAATATTAAGGATTGGGAGGGACATTCATTGCCTCACTCTCTATTTGTTTCACCTTCTGTAAAATTGGTAGAATAATAGTACCCACTTCATAGCATTGTATGATGATTAAATTGGTTAATATTTTTAAAATGCTTAGAACACAGATTGGGCACATAACAGCAAGCACCACATGTGTTTATAAGATAAATTCCCTCGAGGATATCAAGATCTGGCCTCGGCGGCCAAGCTTGGCAATCCGGTACTGTTGGTAAAGCCACCATGGAAGATGCCAAAAACATTAAGAAGGGCCCAGCGCCATTCTACCCACTCGAAGACGGGACCGCCGGCGAGCAGCTGCACAAAGCCATGAAGCGCTACGCCCTGGTGCCCGGCACCATCGCCTTTACCGACGCACATATCGAGGTGGACATTACCTACGCCGAGTACTTCGAGATGAGCGTTCGGCTGGCAGAAGCTATGAAGCGCTATGGGCTGAATACAAACCATCGGATCGTGGTGTGCAGCGAGAATAGCTTGCAGTTCTTCATGCCCGTGTTGGGTGCCCTGTTCATCGGTGTGGCTGTGGCCCCAGCTAACGACATCTACAACGAGCGCGAGCTGCTGAACAGCATGGGCATCAGCCAGCCCACCGTCGTATTCGTGAGCAAGAAAGGGCTGCAAAAGATCCTCAACGTGCAAAAGAAGCTACCGATCATACAAAAGATCATCATCATGGATAGCAAGACCGACTACCAGGGCTTCCAAAGCATGTACACCTTCGTGACTTCCCATTTGCCACCCGGCTTCAACGAGTACGACTTCGTGCCCGAGAGCTTCGACCGGGACAAAACCATCGCCCTGATCATGAACAGTAGTGGCAGTACCGGATTGCCCAAGGGCGTAGCCCTACCGCACCGCACCGCTTGTGTCCGATTCAGTCATGCCCGCGACCCCATCTTCGGCAACCAGATCATCCCCGACACCGCTATCCTCAGCGTGGTGCCATTTCACCACGGCTTCGGCATGTTCACCACGCTGGGCTACTTGATCTGCGGCTTTCGGGTCGTGCTCATGTACCGCTTCGAGGAGGAGCTATTCTTGCGCAGCTTGCAAGACTATAAGATTCAATCTGCCCTGCTGGTGCCCACACTATTTAGCTTCTTCGCTAAGAGCACTCTCATCGACAAGTACGACCTAAGCAACTTGCACGAGATCGCCAGCGGCGGGGCGCCGCTCAGCAAGGAGGTAGGTGAGGCCGTGGCCAAACGCTTCCACCTACCAGGCATCCGCCAGGGCTACGGCCTGACAGAAACAACCAGCGCCATTCTGATCACCCCCGAAGGGGACGACAAGCCTGGCGCAGTAGGCAAGGTGGTGCCCTTCTTCGAGGCTAAGGTGGTGGACTTGGACACCGGTAAGACACTGGGTGTGAACCAGCGCGGCGAGCTGTGCGTCCGTGGCCCCATGATCATGAGCGGCTACGTTAACAACCCCGAGGCTACAAACGCTCTCATCGACAAGGACGGCTGGCTGCACAGCGGCGACATCGCCTACTGGGACGAGGACGAGCACTTCTTCATCGTGGACCGGCTGAAGAGCCTGATCAAATACAAGGGCTACCAGGTAGCCCCAGCCGAACTGGAGAGCATCCTGCTGCAACACCCCAACATCTTCGACGCCGGGGTCGCCGGCCTGCCCGACGACGATGCCGGCGAGCTGCCCGCCGCAGTCGTCGTGCTGGAACACGGTAAAACCATGACCGAGAAGGAGATCGTGGACTATGTGGCCAGCCAGGTTACAACCGCCAAGAAGCTGCGCGGTGGTGTTGTGTTCGTGGACGAGGTGCCTAAAGGACTGACCGGCAAGTTGGACGCCCGCAAGATCCGCGAGATTCTCATTAAGGCCAAGAAGGGCGGCAAGATCGCCGTGTAATAATTCTAGAGTCGGGGCGGCCGGCCGCTTCGAGCAGACATGATAAGATACATTGATGAGTTTGGACAAACCACAACTAGAATGCAGTGAAAAAAATGCTTTATTTGTGAAATTTGTGATGCTATTGCTTTATTTGTAACCATTATAAGCTGCAATAAACAAGTTAACAACAACAATTGCATTCATTTTATGTTTCAGGTTCAGGGGGAGGTGTGGGAGGTTTTTTAAAGCAAGTAAAACCTCTACAAATGTGGTAAAATCGATAAGGATCCGTCGACCGATGCCCTTGAGAGCCTTCAACCCAGTCAGCTCCTTCCGGTGGGCGCGGGGCATGACTATCGTCGCCGCACTTATGACTGTCTTCTTTATCATGCAACTCGTAGGACAGGTGCCGGCAGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGCGGCCGCAAATGCTAAACCACTGCAGTGGTTACCAGTGCTTGATCAGTGAGGCACCGATCTCAGCGATCTGCCTATTTCGTTCGTCCATAGTGGCCTGACTCCCCGTCGTGTAGATCACTACGATTCGTGAGGGCTTACCATCAGGCCCCAGCGCAGCAATGATGCCGCGAGAGCCGCGTTCACCGGCCCCCGATTTGTCAGCAATGAACCAGCCAGCAGGGAGGGCCGAGCGAAGAAGTGGTCCTGCTACTTTGTCCGCCTCCATCCAGTCTATGAGCTGCTGTCGTGATGCTAGAGTAAGAAGTTCGCCAGTGAGTAGTTTCCGAAGAGTTGTGGCCATTGCTACTGGCATCGTGGTATCACGCTCGTCGTTCGGTATGGCTTCGTTCAACTCTGGTTCCCAGCGGTCAAGCCGGGTCACATGATCACCCATATTATGAAGAAATGCAGTCAGCTCCTTAGGGCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCGGTGTTGTCGCTCATGGTAATGGCAGCACTACACAATTCTCTTACCGTCATGCCATCCGTAAGATGCTTTTCCGTGACCGGCGAGTACTCAACCAAGTCGTTTTGTGAGTAGTGTATACGGCGACCAAGCTGCTCTTGCCCGGCGTCTATACGGGACAACACCGCGCCACATAGCAGTACTTTGAAAGTGCTCATCATCGGGAATCGTTCTTCGGGGCGGAAAGACTCAAGGATCTTGCCGCTATTGAGATCCAGTTCGATATAGCCCACTCTTGCACCCAGTTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCGGGGTGTGCAAAAACAGGCAAGCAAAATGCCGCAAAGAAGGGAATGAGTGCGACACGAAAATGTTGGATGCTCATACTCGTCCTTTTTCAATATTATTGAAGCATTTATCAGGGTTACTAGTACGTCTCTCAAGGATAAGTAAGTAATATTAAGGTACGGGAGGTATTGGACAGGCCGCAATAAAATATCTTTATTTTCATTACATCTGTGTGTTGGTTTTTTGTGTGAATCG

PEGLN1 (human) -Fluc

Product Specifications

Applications

Storage Temperature

Plasmid Hos

Inserted Fragment Type

Inserted Fragment Species

Resistance

Fluorescent labeling

Competent cells

Nucleic Acid Sequence

Gene Length

Frequently Asked Questions

Explore Other Products

Mouse Galectin-9 Recombinant Protein

Lentiviral human TM2D1 shRNA (UAS) - Lentiviral human TM2D1 shRNA (UAS, RFP) (25)

Regorafenib Impurity 77

Regorafenib Impurity 77

Regorafenib Impurity 77

Regorafenib Impurity 77